Modulation of angiogenesis for cancer prevention: strategies based on antioxidants and copper deficiency

Area of Science:

• Oncology
• Translational Research
• Cancer Prevention

Background:

• Anti-angiogenesis strategies are primarily explored for therapeutic applications.
• The potential of these strategies for cancer prevention remains largely unknown.
• Modulating the cancer angiogenic switch early in tumor progression is a key area of interest.

Purpose of the Study:

• To review progress in anti-angiogenesis for cancer prevention.
• To assess the feasibility of long-term chemopreventive measures using anti-angiogenic interventions.
• To highlight promising strategies such as antioxidant nutraceuticals and copper deficiency.

Main Methods:

• Review of in vitro and in vivo models.
• Analysis of anti-angiogenic interventions for chemoprevention.
• Examination of antioxidant nutraceuticals and copper deficiency as potential strategies.

Main Results:

• In vitro and in vivo models suggest anti-angiogenic interventions are suitable for long-term chemoprevention.
• Antioxidant nutraceuticals and copper deficiency are identified as nearly ready for application.
• These strategies serve as paradigms for translational research in cancer prevention.

Conclusions:

• Anti-angiogenic strategies hold potential for long-term cancer chemoprevention.
• Specific approaches like antioxidant nutraceuticals and copper deficiency are promising.
• Further translational research is crucial to advance these preventive measures.